Radioimmunotherapy of CD20 Positive B-Cell Non-Hodgkin Lymphoma - Radiation Safety Considerations and First Results

被引：0
|
作者：
Sandrock, D. [1 ]
Dopichaj, U. [1 ]
Geworski, L. [1 ]
Munz, D. L. [1 ]
机构：
[1] Charite, Clin Nucl Med, Berlin, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [41] The use of ibritumomab tiuxetan radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma
    Witzig, TE
    [J]. SEMINARS IN ONCOLOGY, 2000, 27 (06) : 74 - 78
  • [42] Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: From clinical trials to clinical practice
    Juweid, ME
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (11) : 1507 - 1529
  • [43] Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma
    Eskian, Mahsa
    Khorasanizadeh, MirHojjat
    Zinzani, Pier L.
    Rezaei, Nima
    [J]. IMMUNOTHERAPY, 2018, 10 (08) : 699 - 711
  • [44] Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
    Sacchi, S
    Federico, M
    Dastoli, G
    Fiorani, C
    Vinci, G
    Clò, V
    Casolari, B
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 13 - 25
  • [45] Radioimmunotherapy in relapsed or refractory B-cell non-hodgkin's lymphoma with I-131-labeled chimericanti CD20 C2B8 (I-131 rituximab)
    Kang, H. J.
    Park, Y. H.
    Kim, S.
    Cheon, G. J.
    Choi, C. W.
    Lim, S. M.
    Lee, S. S.
    Na, I. I.
    Ryoo, B. Y.
    Yang, S. H.
    Kim, W. S.
    Kim, K. H.
    Bang, S. M.
    Yuh, Y. J.
    Nam, S. H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 109
  • [46] Hemophagocytic syndrome as the initial manifestation of CD20(+) B-cell non-Hodgkin lymphoma with EGFR(+) lung adenocarcinoma: a case report and literature review
    Yang, Wei
    Zhang, Xue-Jin
    Xu, Xiao-Feng
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 6183 - 6188
  • [47] CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20(+), surface CD20(-)
    Yokose, Norio
    Shioi, Yumiko
    Sugisaki, Yuich
    Ohaki, Yoshiharu
    Ogata, Kiyoyuki
    Dan, Kazuo
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1415 - 1417
  • [48] Aberrant Expression of CD8 in B-Cell Non-Hodgkin Lymphoma
    Carulli, Giovanni
    Stacchini, Alessandra
    Marini, Alessandra
    Ciriello, Maria Matilde
    Zucca, Alessandra
    Cannizzo, Elisa
    Aliberti, Sabrina
    Demurtas, Anna
    Novero, Domenico
    Calcagno, Lara
    Callegari, Tiziana
    Petrini, Mario
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 186 - 190
  • [49] Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin's lymphomas (NHL)
    Tsai, Ping-Chiao
    Nayeen, Bangia
    Olejniczak, Scott
    Hernandez-Ilizaliturri, Francisco
    Czuczman, Myron
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184
  • [50] MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
    Lim, Emilia L.
    Marra, Marco A.
    [J]. BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2013, 3 : 25 - 40
12345